Xu D
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- RNA Interference and Gene Delivery 9
- Advanced biosensing and bioanalysis techniques 5
- DNA and Nucleic Acid Chemistry 4
- Epidemiology 23
- Inflammatory Myopathies and Dermatomyositis 15
- Co-authors
- R. L. Juliano (7 shared papers)Peiheng He (13 shared papers)Michael H. Fisher (4 shared papers)Xiaofeng Zeng (20 shared papers)Ziji Zhang (6 shared papers)Qian Wang (20 shared papers)Mengtao Li (16 shared papers)Suraiya Rasheed (1 shared paper)
- Journals
- Clinical Rheumatology (5 papers)PLoS ONE (2 papers)Frontiers in Immunology (2 papers)Molecular Pharmacology (2 papers)Cellular Physiology and Biochemistry (2 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Xu D
129 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 230
- Virology 63
- Rheumatology 139
- Molecular Biology 657
- Immunology 176
Countries citing papers authored by Xu D
This map shows the geographic impact of Xu D's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu D with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu D more than expected).
Fields of papers citing papers by Xu D
This network shows the impact of papers produced by Xu D. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu D. The network helps show where Xu D may publish in the future.
Co-authors
The 25 scholars most cited alongside Xu D, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 72 | |
| 2 | 1996 | 66 | |
| 3 | 2014 | 62 | |
| 4 | 2007 | 59 | |
| 5 | 2013 | 56 | |
| 6 | 2013 | 56 | |
| 7 | 2019 | 52 | |
| 8 | 2015 | 50 | |
| 9 | 2019 | 48 | |
| 10 | 2004 | 44 | |
| 11 | miR-141 modulates osteoblastic cell proliferation by regulating the target gene of lncRNA H19 and lncRNA H19-derived miR-675. | 2016 | 43 |
| 12 | 2002 | 42 | |
| 13 | 2018 | 42 | |
| 14 | 2016 | 41 | |
| 15 | 2015 | 35 | |
| 16 | 2015 | 35 | |
| 17 | 2007 | 33 | |
| 18 | 2015 | 31 | |
| 19 | 2022 | 29 | |
| 20 | 2014 | 25 |
About Xu D
Xu D is a scholar working on Molecular Biology, Epidemiology, Rheumatology, Oncology and Cancer Research, having authored 137 papers that have together received 1.7k indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (15 papers), RNA Interference and Gene Delivery (9 papers), Systemic Sclerosis and Related Diseases (7 papers), Advanced biosensing and bioanalysis techniques (5 papers), Cancer-related molecular mechanisms research (4 papers), Virus-based gene therapy research (4 papers), DNA and Nucleic Acid Chemistry (4 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). The work is most often cited by research in Cancer Research (230 citations), Virology (63 citations), Rheumatology (139 citations), Molecular Biology (657 citations) and Immunology (176 citations). Xu D has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include R. L. Juliano, Peiheng He, Michael H. Fisher, Xiaofeng Zeng, Ziji Zhang, Qian Wang, Mengtao Li, Suraiya Rasheed, Zhiliang Li and Andrea Kovács. Their work appears in journals such as Clinical Rheumatology, PLoS ONE, Frontiers in Immunology, Molecular Pharmacology and Cellular Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.